An observational study of Controlled Release Nitroglycerin in patients with angina.
- Conditions
- Health Condition 1: I209- Angina pectoris, unspecifiedHealth Condition 2: null- Male/Female patient with sign/symptoms of Angina Pectoris.
- Registration Number
- CTRI/2018/10/016215
- Lead Sponsor
- Care Lifescience Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1Patients with Normal Sinus Rhythm on ECG at Screening
2Patients who have signed Written Informed Consent
3Patients with stable/unstable or Prinzmetals angina for at least 3 months prior to inclusion (mild/moderate/severe)
4Male or Female patients > 18 years and < 75 years of age.
1Male or Female patients < 18 years and > 75 years of age
2Congestive heart failure stage III or IV NYHA.
3Symptomatic hypotension.
4Atrial fibrillation, flutter, pacemaker or cardioverter-defibrillator implantation
5History of serious abnormal drug reaction.
6Patients with Postural hypotension
7Patients with chronic kidney failure
8History of any serious infectious disease like Hepatitis B or C, HIV etc.
9History of severe psychiatric or behavioral disorders likely to interfere with the study.
10Patients with other severe disease likely to interfere with the study in the investigators judgment.
11Pregnant and lactating women.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method